U.S. markets open in 9 hours 18 minutes
  • S&P Futures

    4,307.25
    -0.50 (-0.01%)
     
  • Dow Futures

    34,132.00
    +14.00 (+0.04%)
     
  • Nasdaq Futures

    13,646.25
    -12.00 (-0.09%)
     
  • Russell 2000 Futures

    2,024.70
    +1.40 (+0.07%)
     
  • Crude Oil

    87.10
    +0.57 (+0.66%)
     
  • Gold

    1,790.30
    +0.60 (+0.03%)
     
  • Silver

    20.05
    -0.03 (-0.17%)
     
  • EUR/USD

    1.0174
    +0.0003 (+0.03%)
     
  • 10-Yr Bond

    2.8240
    +0.0330 (+1.18%)
     
  • Vix

    19.69
    -0.26 (-1.30%)
     
  • GBP/USD

    1.2101
    +0.0007 (+0.06%)
     
  • USD/JPY

    134.1700
    -0.0450 (-0.03%)
     
  • BTC-USD

    24,027.58
    -100.28 (-0.42%)
     
  • CMC Crypto 200

    572.98
    +1.07 (+0.19%)
     
  • FTSE 100

    7,536.06
    +26.91 (+0.36%)
     
  • Nikkei 225

    29,144.05
    +275.14 (+0.95%)
     

ResMed Announces Participation in the Citi Healthcare Conference

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
ResMed Inc.
ResMed Inc.

SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Citi Healthcare Conference on Wednesday, February 23, 2022, beginning at approximately 12:30 p.m. (Eastern Standard Time) via webcast.

More information about this event, including access to the live webcast, may be accessed by visiting https://investor.resmed.com. The webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible through February 23, 2023.

About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.

For investors

For media

Amy Wakeham

Jayme Rubenstein

+1 858.836.5000

+1 858.836.6798

investorrelations@resmed.com

news@resmed.com